, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Biomarkers Definitions Working Group, vol.69, pp.89-95, 2001.

G. M. Macmahon and S. S. Waikar, Biomarkers in Nephrology. Am J Kidney Dis, vol.62, pp.165-178, 2013.

C. L. Edelstein, Biomarkers in Kidney Disease, 2011.

J. A. Van-den-brand, J. M. Hofstra, and J. F. Wetzels, Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy, Clin J Am Soc Nephrol, vol.6, pp.2846-2853, 2011.

M. V. Irazabal, A. Eirin, and J. Lieske, Low-and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study, Nephrol Dial Transplant, vol.28, pp.137-146, 2013.

C. Bazzi, V. Rizza, and G. Olivieri, Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-?-D-glucosaminidase in glomerulonephritis, J Nephrol, 2014.

F. Fervenza, D. Vriese, and A. Con, Biomarkers in glomerular diseases : putting the cart before the wheel?, Nephrol Dial Transplant, vol.30, pp.885-890, 2015.

S. M. Herrmann, S. Sethi, and F. C. Fervenza, Membranous nephropathy: the start of a paradigm shift, Curr Opin Nephrol Hypertens, vol.21, pp.203-210, 2012.

L. C. Clement, C. Avila-casado, and C. Macé, Podocyte-secreted angiopoietinlike-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome, Nat Med, vol.17, pp.117-122, 2011.

J. Reiser and H. Chapman, Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shaken, J Am Soc Nephrol, vol.25, pp.1611-1613, 2014.

C. C. Yu, A. Fornoni, and A. Weins, Abatacept in B7-1-positive proteinuric kidney disease, N Engl J Med, vol.369, pp.2416-2423, 2013.

R. J. Macisaac, E. I. Ekinci, and G. Jerums, Markers of and risk factors for the development and progression of diabetic kidney disease, Am J Kidney Dis, vol.63, pp.39-62, 2014.

H. I. Brunner, M. R. Bennett, and R. Mina, Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis, Arthritis Rheum, vol.64, pp.2687-2697, 2012.

L. H. Mariani, M. Kretzler, and . Pro, The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism-individual patient variability in disease presentation, course and response to therapy, Nephrol Dial Transplant, vol.30, pp.892-898, 2015.

P. Ronco and J. Floege, Ten-year advances in immunopathology of glomerulonephritis: translated into patients' care or lost in translation?, Semin Immunopathol, vol.36, pp.377-379, 2014.

H. C. Stanescu, M. Arcos-burgos, and A. Medlar, Risk HLA-DQA1 and PLA (2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, vol.364, pp.616-626, 2011.

L. H. Beck, . Jr, R. G. Bonegio, and G. Lambeau, M-type phospholipase A2 receptor as target antigen in idiopathic MN, N Engl J Med, vol.361, pp.11-21, 2009.

P. Ronco and H. Debiec, Membranous nephropathy: recent pathophysiological advances leading to a paradigm shift in patient's care, Lancet, 2015.

P. Ruggenenti, H. Debiec, and B. Ruggiero, Anti-PLA2R antibody titer predicts post-rituximab outcome of membranous nephropathy, J Am Soc Nephrol, vol.25, pp.1786-1798, 2014.

N. M. Tomas, L. H. Beck, . Jr, and C. Meyer-schwesinger, Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, pp.2277-2287, 2014.

D. Abreu, F. B. Wells, W. A. Tsongalis, and G. J. , The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine, Am J Pathol, vol.183, pp.1075-1083, 2013.

B. A. Molitoris, Urinary biomarkers: alone are they enough?, J Am Soc Nephrol, 2014.